ADIM
KVUE icon

Alpha DNA Investment Management’s Kenvue KVUE Stock Holding History

Alpha DNA Investment Management’s Portfolio KVUE Stock Details KVUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-55,972
Closed -$1.29M – 226
2024
Q3 		$1.29M Sell
55,972
-57,595
-51% -$1.19M 0.48% 38
2024
Q2 		$2.06M Buy
113,567
+26,453
+30% +$513K 0.8% 22
2024
Q1 		$1.87M Sell
87,114
-2,754
-3% -$55.9K 0.69% 32
2023
Q4 		$1.93M Buy
+89,868
New +$1.8M 0.75% 24

Other funds holding KVUE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Alpha DNA Investment Management's KVUE Position: Q4 2024 in Review

Alpha DNA Investment Management sold out of Kenvue (KVUE) in Q4 2024, closing a stake of 55,972 shares — an estimated $1.29M sold.

Alpha DNA Investment Management first reported a position in KVUE in Q4 2023 and held it in 4 quarters. The position peaked at $2.06M in Q2 2024. 1,011 funds tracked by Wall St. Rank hold KVUE as of Q4 2024.

  • Alpha DNA Investment Management reported no remaining Kenvue position as of Q4 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 55,972 Kenvue shares in Q4 2024, an estimated $1.29M.
  • Alpha DNA Investment Management first reported a position in Kenvue in Q4 2023 and held it in 4 quarters.
  • Alpha DNA Investment Management's Kenvue position peaked at $2.06M in Q2 2024.
  • 1,011 funds tracked by Wall St. Rank held Kenvue as of Q4 2024.

Based on Alpha DNA Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.